Page last updated: 2024-09-05

bw 501c and cinanserin

bw 501c has been researched along with cinanserin in 1 studies

Compound Research Comparison

Studies
(bw 501c)
Trials
(bw 501c)
Recent Studies (post-2010)
(bw 501c)
Studies
(cinanserin)
Trials
(cinanserin)
Recent Studies (post-2010) (cinanserin)
17002451246

Protein Interaction Comparison

ProteinTaxonomybw 501c (IC50)cinanserin (IC50)
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)0.002
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus5
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 25
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.002
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)0.002
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.182

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knowles, ID; Ramage, AG1

Other Studies

1 other study(ies) available for bw 501c and cinanserin

ArticleYear
Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anaesthetized rats.
    British journal of pharmacology, 1999, Volume: 128, Issue:3

    Topics: Amidines; Amphetamines; Animals; Antidiuretic Hormone Receptor Antagonists; Atropine Derivatives; Blood Pressure; Cardiovascular Physiological Phenomena; Cinanserin; Injections, Intraventricular; Male; Polyethylene Glycols; Quipazine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Serotonin Antagonists; Spiperone

1999